[Interstitial lung disease in rheumatoid arthritis].
Uno-Komase
Y
Y
Department of Internal Medicine, St. Marianna University, Toyoko Hospital.
Azuma
T
T
D000368:Aged; D018501:Antirheumatic Agents / Q000009:adverse effects; D001172:Arthritis, Rheumatoid / Q000150:complications* / Q000188:drug therapy; D001989:Bronchiolitis Obliterans / Q000209:etiology; D001992:Bronchoalveolar Lavage Fluid; D005260:Female; D006801:Humans; D008297:Male; D008727:Methotrexate / Q000009:adverse effects; D008875:Middle Aged; D050607:Organogold Compounds; D010396:Penicillamine / Q000009:adverse effects; D011239:Prednisolone / Q000008:administration & dosage; D011379:Prognosis; D011658:Pulmonary Fibrosis / Q000139:chemically induced / Q000188:drug therapy / Q000209:etiology*; D012129:Respiratory Function Tests
D018501:Antirheumatic Agents; D050607:Organogold Compounds; D011239:Prednisolone; D010396:Penicillamine; D008727:Methotrexate